SEC Sues 8 For Insider Trading In Sanofi, Chattem Deal

Law360, New York (August 28, 2012, 8:52 PM EDT) -- The U.S. Securities and Exchange Commission on Tuesday sued several Georgia men who allegedly traded ahead of Sanofi-Aventis Inc.'s purchase of Tennessee-based drug company Chattem Inc. using information from a Chattem board member’s accountant.

The SEC says Thomas Melvin, a Griffin, Ga., accountant for a Chattem board member, tipped a group of associates in 2009 about the company's then-upcoming sale to Sanofi. The eight insider traders made $500,000 profit trading in Chattem, which sells over-the-counter pharmaceuticals Allegra, Gold Bond and Icy Hot.

“It is particularly troubling...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.